Library / Laws / 114th Congress / House Bills / H.R. 2416
H.R. 2416
To amend the Federal Food, Drug, and Cosmetic Act to evaluate the potential use of evidence from clinical experience to help support the approval of new indications for approved drugs, and for other purposes.
| Print stage | Date | Size | ⠃ |
|---|---|---|---|
| Introduced in House | 2015-05-19 | 4.5K | ⠃⠗⠋ |